Impact of diabetes against the future risk of developing gout
暂无分享,去创建一个
[1] M. Wallander,et al. Trends in the prevalence and incidence of diabetes in the UK: 1996–2005 , 2009, Journal of Epidemiology & Community Health.
[2] Hyon K. Choi,et al. Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile. , 2008, Rheumatology.
[3] Giuseppe Lippi,et al. High Serum Uric Acid as a Novel Risk Factor for Type 2 Diabetes , 2008, Diabetes Care.
[4] O. Kano,et al. GOUT AND RISK OF PARKINSON DISEASE: A PROSPECTIVE STUDY , 2008, Neurology.
[5] E. Ford,et al. Haemoglobin A1c, fasting glucose, serum C-peptide and insulin resistance in relation to serum uric acid levels--the Third National Health and Nutrition Examination Survey. , 2008, Rheumatology.
[6] L. Annemans,et al. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005 , 2007, Annals of the rheumatic diseases.
[7] Hyon K. Choi,et al. Independent Impact of Gout on Mortality and Risk for Coronary Heart Disease , 2007, Circulation.
[8] C. Scavone,et al. Neutrophil function and metabolism in individuals with diabetes mellitus. , 2007, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[9] Hyon K. Choi,et al. Prevalence of the metabolic syndrome in individuals with hyperuricemia. , 2007, The American journal of medicine.
[10] Chaoyang Li,et al. Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. , 2007, Arthritis and rheumatism.
[11] P Netter,et al. EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT) , 2006, Annals of the rheumatic diseases.
[12] P Netter,et al. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT) , 2006, Annals of the rheumatic diseases.
[13] R. Coimbra,et al. MODULATION OF LIPOPOLYSACCHARIDE-INDUCED ACUTE LUNG INFLAMMATION: ROLE OF INSULIN , 2006, Shock.
[14] L. Niskanen,et al. Serum uric acid as a harbinger of metabolic outcome in subjects with impaired glucose tolerance: the Finnish Diabetes Prevention Study. , 2006, Diabetes care.
[15] R. Curi,et al. Role of insulin on PGE2 generation during LPS-induced lung inflammation in rats. , 2006, Life sciences.
[16] Hyon K. Choi,et al. Pathogenesis of Gout , 2005, Annals of Internal Medicine.
[17] K. Greco,et al. Lymphatic system changes in diabetes mellitus: role of insulin and hyperglycemia , 2005, Diabetes/metabolism research and reviews.
[18] W. Bilker,et al. Gout epidemiology: results from the UK General Practice Research Database, 1990–1999 , 2005, Annals of the rheumatic diseases.
[19] P. Sannomiya,et al. Inhibition of leukocyte chemotaxis by serum factor in diabetes mellitus: Selective depression of cell responses mediated by complement-derived chemoattractants , 1990, Agents and Actions.
[20] A. Bourke,et al. Feasibility study and methodology to create a quality-evaluated database of primary care data. , 2004, Informatics in primary care.
[21] M. Martins,et al. Down-regulation of mast cell activation and airway reactivity in diabetic rats: role of insulin , 2004, European Respiratory Journal.
[22] Z. Fortes,et al. Probucol restores the defective leukocyte-endothelial interaction in experimental diabetes. , 2003, European journal of pharmacology.
[23] A. Fam. Gout, diet, and the insulin resistance syndrome. , 2002, The Journal of rheumatology.
[24] P. Chou,et al. Gender differences in the relationships of serum uric acid with fasting serum insulin and plasma glucose in patients without diabetes. , 2001, The Journal of rheumatology.
[25] V. Lagente,et al. Endotoxin-induced acute lung injury in rats. Role of insulin. , 1999, Pulmonary pharmacology & therapeutics.
[26] B. Emmerson. Hyperlipidaemia in hyperuricaemia and gout , 1998, Annals of the rheumatic diseases.
[27] W. Rathmann,et al. Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study. Coronary Artery Risk Development in Young Adults. , 1998, Annals of epidemiology.
[28] H. Jick,et al. Omeprazole, other antiulcer drugs and newly diagnosed gout. , 2003, British journal of clinical pharmacology.
[29] P. Vokonas,et al. Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome. The Normative Aging Study. , 1995, American journal of epidemiology.
[30] T. Whitehead,et al. Serum Urate, Serum Glucose and Diabetes , 1992, Annals of clinical biochemistry.
[31] Z. Fortes,et al. Direct Vital Microscopic Study of Defective Leukocyte-Endothelial Interaction in Diabetes Mellitus , 1991, Diabetes.
[32] H. King,et al. Plasma uric acid level and its association with diabetes mellitus and some biologic parameters in a biracial population of Fiji. , 1988, American journal of epidemiology.
[33] M. Pereira,et al. Inhibition of Leukocyte Chemotaxis by Factor in Alloxan-Induced Diabetic Rat Plasma , 1987, Diabetes.
[34] D. Cook,et al. Serum uric acid, serum glucose and diabetes: relationships in a population study. , 1986, Postgraduate medical journal.
[35] Z. Fortes,et al. Vascular reactivity in diabetes mellitus: possible role of insulin on the endothelial cell , 1984, British journal of pharmacology.
[36] Z. Fortes,et al. Vascular reactivity in diabetes mellitus: role of the endothelial cell , 1983, British journal of pharmacology.
[37] U. Goldbourt,et al. URIC ACID AND DIABETES: OBSERVATIONS IN A POPULATION STUDY , 1982, The Lancet.
[38] G. Böhm,et al. Decreased vascular reactions to permeability factors in experimental diabetes. , 1976, British journal of experimental pathology.
[39] G. Böhm,et al. Possible participation of insulin in the control of vascular permeability. , 1974, European journal of pharmacology.
[40] M. Silva,et al. Pharmacological analysis of the acute inflammatory process induced in the rat's paw by local injection of carrageenin and by heating , 1973, British journal of pharmacology.